Report Detail
Global Conjunctivitis Market Insights, Forecast to 2025
- RnM2652177 |
- 05 April, 2019 |
- Global |
- 113 Pages |
- QYResearch |
- Pharma & Healthcare
Conjunctivitis, or inflammation of the conjunctiva, is a general term that refers to a diverse group of diseases/disorders that affect the conjunctiva primarily. Most varieties of conjunctivitis are self-limited, but some progress and may cause serious ocular and extraocular complications.
The technical barriers of conjunctivitis industry are existed apparently. The key technology and higher level products are in the hand of the global leading enterprise like Novartis, Santen Pharmaceutical, Bausch + Lomb, Allergan, Sun Pharmaceutical, Akorn, Sinqi, etc.
The unmet need for viral conjunctivitis is the key driver for the growth of this market. Since there are no approved drugs for the treatment of viral conjunctivitis, many companies and researchers are now developing drugs that are in the clinical stage of development. These drugs are expected to aid in the treatment of viral conjunctivitis and their effectiveness will in turn promote growth in this market in the next four years.
The global Conjunctivitis market is valued at 3330 million US$ in 2018 and will reach 3790 million US$ by the end of 2025, growing at a CAGR of 1.6% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Conjunctivitis market based on company, product type, end user and key regions.
This report studies the global market size of Conjunctivitis in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Conjunctivitis in these regions.
This research report categorizes the global Conjunctivitis market by top players/brands, region, type and end user. This report also studies the global Conjunctivitis market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Allergan, Inc
Merck
Pfizer, Inc.
Novartis
Market size by Product
Antibiotic
Pills
Ointment
Market size by End User
Newborns
Children
Adults
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Conjunctivitis market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Conjunctivitis market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Conjunctivitis companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Conjunctivitis submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Conjunctivitis are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Conjunctivitis market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Conjunctivitis Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Conjunctivitis Market Size Growth Rate by Product
- 1.4.2 Antibiotic
- 1.4.3 Pills
- 1.4.4 Ointment
- 1.5 Market by End User
- 1.5.1 Global Conjunctivitis Market Size Growth Rate by End User
- 1.5.2 Newborns
- 1.5.3 Children
- 1.5.4 Adults
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Conjunctivitis Market Size
- 2.1.1 Global Conjunctivitis Revenue 2014-2025
- 2.1.2 Global Conjunctivitis Sales 2014-2025
- 2.2 Conjunctivitis Growth Rate by Regions
- 2.2.1 Global Conjunctivitis Sales by Regions
- 2.2.2 Global Conjunctivitis Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Conjunctivitis Sales by Manufacturers
- 3.1.1 Conjunctivitis Sales by Manufacturers
- 3.1.2 Conjunctivitis Sales Market Share by Manufacturers
- 3.1.3 Global Conjunctivitis Market Concentration Ratio (CR5 and HHI)
- 3.2 Conjunctivitis Revenue by Manufacturers
- 3.2.1 Conjunctivitis Revenue by Manufacturers (2014-2019)
- 3.2.2 Conjunctivitis Revenue Share by Manufacturers (2014-2019)
- 3.3 Conjunctivitis Price by Manufacturers
- 3.4 Conjunctivitis Manufacturing Base Distribution, Product Types
- 3.4.1 Conjunctivitis Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Conjunctivitis Product Type
- 3.4.3 Date of International Manufacturers Enter into Conjunctivitis Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Conjunctivitis Sales by Product
- 4.2 Global Conjunctivitis Revenue by Product
- 4.3 Conjunctivitis Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Conjunctivitis Breakdown Data by End User
6 North America
- 6.1 North America Conjunctivitis by Countries
- 6.1.1 North America Conjunctivitis Sales by Countries
- 6.1.2 North America Conjunctivitis Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Conjunctivitis by Product
- 6.3 North America Conjunctivitis by End User
7 Europe
- 7.1 Europe Conjunctivitis by Countries
- 7.1.1 Europe Conjunctivitis Sales by Countries
- 7.1.2 Europe Conjunctivitis Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Conjunctivitis by Product
- 7.3 Europe Conjunctivitis by End User
8 Asia Pacific
- 8.1 Asia Pacific Conjunctivitis by Countries
- 8.1.1 Asia Pacific Conjunctivitis Sales by Countries
- 8.1.2 Asia Pacific Conjunctivitis Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Conjunctivitis by Product
- 8.3 Asia Pacific Conjunctivitis by End User
9 Central & South America
- 9.1 Central & South America Conjunctivitis by Countries
- 9.1.1 Central & South America Conjunctivitis Sales by Countries
- 9.1.2 Central & South America Conjunctivitis Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Conjunctivitis by Product
- 9.3 Central & South America Conjunctivitis by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Conjunctivitis by Countries
- 10.1.1 Middle East and Africa Conjunctivitis Sales by Countries
- 10.1.2 Middle East and Africa Conjunctivitis Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Conjunctivitis by Product
- 10.3 Middle East and Africa Conjunctivitis by End User
11 Company Profiles
- 11.1 Allergan, Inc
- 11.1.1 Allergan, Inc Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Allergan, Inc Conjunctivitis Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Allergan, Inc Conjunctivitis Products Offered
- 11.1.5 Allergan, Inc Recent Development
- 11.2 Merck
- 11.2.1 Merck Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Merck Conjunctivitis Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Merck Conjunctivitis Products Offered
- 11.2.5 Merck Recent Development
- 11.3 Pfizer, Inc.
- 11.3.1 Pfizer, Inc. Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Pfizer, Inc. Conjunctivitis Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Pfizer, Inc. Conjunctivitis Products Offered
- 11.3.5 Pfizer, Inc. Recent Development
- 11.4 Novartis
- 11.4.1 Novartis Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Novartis Conjunctivitis Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Novartis Conjunctivitis Products Offered
- 11.4.5 Novartis Recent Development
12 Future Forecast
- 12.1 Conjunctivitis Market Forecast by Regions
- 12.1.1 Global Conjunctivitis Sales Forecast by Regions 2019-2025
- 12.1.2 Global Conjunctivitis Revenue Forecast by Regions 2019-2025
- 12.2 Conjunctivitis Market Forecast by Product
- 12.2.1 Global Conjunctivitis Sales Forecast by Product 2019-2025
- 12.2.2 Global Conjunctivitis Revenue Forecast by Product 2019-2025
- 12.3 Conjunctivitis Market Forecast by End User
- 12.4 North America Conjunctivitis Forecast
- 12.5 Europe Conjunctivitis Forecast
- 12.6 Asia Pacific Conjunctivitis Forecast
- 12.7 Central & South America Conjunctivitis Forecast
- 12.8 Middle East and Africa Conjunctivitis Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Conjunctivitis Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Conjunctivitis . Industry analysis & Market Report on Conjunctivitis is a syndicated market report, published as Global Conjunctivitis Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Conjunctivitis market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
